Skip to main content
. 2022 Mar 14;7:90. [Version 1] doi: 10.12688/wellcomeopenres.17682.1

Figure 2c. Blood and urine sampling times and volumes during inpatient stay and out-patient follow-up – multiple oral dosing.

Figure 2c.

βHCG, Beta-human chorionic gonadotrophin; D, day; NA, not applicable; RDT, rapid diagnostic test; PD, pharmacodynamics; PK, pharmacokinetics.

Figure 2c is based on an assumed dosing duration of 30-hours. This may vary depending on emerging data and could extend up to a maximum of 72-hours.